Terumo 

€11.80
45
-€0.30-2.48% 06:04 Today

Statistics

Day High
11.8
Day Low
11.8
52W High
14.6
52W Low
9.75
Volume
-
Avg. Volume
-
Mkt Cap
17.47B
P/E Ratio
25.6
Dividend Yield
1.35%
Dividend
0.16

Upcoming

Dividends

1.35%Dividend Yield
Jul 26
€0.08
Dec 25
€0.08
Jul 25
€0.08
Dec 24
€0.08
Jul 24
€0.06
10Y Growth
0.23%
5Y Growth
7.87%
3Y Growth
7.61%
1Y Growth
1.68%

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.07
0.13
0.19
0.25
Expected EPS
0.1506013993206672
Actual EPS
N/A

Financials

11.26%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
6.3BRevenue
709.02MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TUO0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap120.46B
Medtronic is a global leader in medical technology, services, and solutions, competing directly with Terumo in areas such as cardiovascular and hospital products.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a range of interventional medical specialties, offering products that compete with Terumo's portfolio.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories operates in various segments, including vascular devices, which directly competes with Terumo's product offerings in the cardiovascular market.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices segment, competes in the healthcare market, offering products that overlap with Terumo's range, especially in surgical and cardiovascular technologies.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. develops, manufactures, and markets products that save and sustain the lives of people, competing with Terumo in the areas of hospital and surgical products.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, directly competing with Terumo in the cardiovascular market.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation is one of the world's leading medical technology companies, offering products that compete with Terumo in surgical and hospital settings.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products, which indirectly competes with Terumo's offerings in the healthcare sector.
Becton Dickinson
BDX
Mkt Cap50.32B
Becton, Dickinson and Company is a global medical technology company that competes with Terumo in the development and sale of medical devices, instrument systems, and reagents.

About

Terumo Corporation is a global medical technology company dedicated to the manufacturing and sale of a wide array of medical products and equipment, operating through three distinct business segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular division provides critical devices for cardiovascular and cerebrovascular interventions, including angiographic guidewires, various catheters (angiographic, PTCA balloon, imaging), introducer sheaths, vascular closure devices, coronary and self-expanding peripheral stents, and intravascular ultrasound systems; it also develops specialized tools for cerebral aneurysm treatment like coils, stents, and intrasaccular devices, as well as embolization systems, aspiration catheters, and clot retrievers for ischemic stroke, further supplying oxygenators, cardio-pulmonary bypass systems, and artificial vascular and stent grafts. The Medical Care Solutions segment offers a comprehensive range of general medical products such as syringes, infusion and syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritional products, and adhesion barriers; for patient self-care, it provides blood glucose monitoring systems, disposable needles for pen-injectors, insulin patch pumps, blood pressure monitors, and digital thermometers, while also performing contract manufacturing for pharmaceutical companies, producing prefillable syringes and needles for drug packaging. The Blood and Cell Technologies division focuses on innovations in blood and cell management, offering products such as blood bags, component collection systems, automated blood processing and pathogen reduction systems, centrifugal apheresis systems, and cell expansion systems. Originally founded in 1921 as Sekisen Ken-onki Corporation, the company adopted the name Terumo Corporation in October 1974 and maintains its headquarters in Tokyo, Japan.
Show more...
CEO
Hikaru Samejima
Employees
30207
Country
Japan
ISIN
US88156J1051
WKN
000A0YHJ7

Listings

0 Comments

Share your thoughts

FAQ

What is Terumo stock price today?
The current price of TUO0.F is €11.80 EUR — it has decreased by -2.48% in the past 24 hours. Watch Terumo stock price performance more closely on the chart.
What is Terumo stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Terumo stocks are traded under the ticker TUO0.F.
What is Terumo market cap?
Today Terumo has the market capitalization of 17.47B
When is the next Terumo earnings date?
Terumo is going to release the next earnings report on November 05, 2026.
What were Terumo earnings last quarter?
TUO0.F earnings for the last quarter are 0.25 EUR per share, whereas the estimation was 0.14 EUR resulting in a +84.43% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Terumo revenue for the last year?
Terumo revenue for the last year amounts to 6.3B EUR.
What is Terumo net income for the last year?
TUO0.F net income for the last year is 709.02M EUR.
Does Terumo pay dividends?
Yes, TUO0.F dividends are paid semi-annual. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (FWD)% is 1.35%.
How many employees does Terumo have?
As of September 10, 2026, the company has 30,207 employees.
In which sector is Terumo located?
Terumo operates in the Health & Wellness sector.
When did Terumo complete a stock split?
The last stock split for Terumo was on April 09, 2024 with a ratio of 2:1.
Where is Terumo headquartered?
Terumo is headquartered in Tokyo, Japan.